sort: date |  title |  url

SEAS Trial Checks Merck-Schering-Plough
The SEAS trial will reveal outcomes from a test of the drug Vytorin. Sales have been badly hurt this year due to failure of the drug to cut plaque.
07-21-2008 and 1 other Tags alzheimers, arteriochlerosis, atheroschlerosis, hdl, ldl, merck, vytorin, zetia

Social bookmarking by scuttlePLUS.